/
EMOR
$0.06-$0.01 (-9.87%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $0.07
86% from low
Exchange
OTC Link
CS
Borrow rate
0.64%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-0.62
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.7K | $117.9K | $59.4K | $0 | $8.8K | $598.9K | $702.9K | −$94.4K |
| Cost of revenue | $6.0K | $172.9K | $109.0K | $23.0K | $33.1K | $388.1K | $308.8K | $0 |
| Gross profit | $724 | −$54.9K | −$49.5K | −$23.0K | −$24.3K | $210.8K | $394.1K | $0 |
| Gross margin | 10.8% | -46.6% | -83.3% | — | -275.3% | 35.2% | 56.1% | 0.0% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$304.4K | −$1.1M | −$3.1M | −$2.6M | −$555.1K | −$6.4M | −$475.1K | −$1.0M |
| EBITDA | −$330.7K | −$997.2K | −$15.0M | −$2.6M | −$522.0K | −$6.3M | −$464.1K | −$1.0M |
| Net income | −$336.7K | −$1.1M | −$15.1M | −$2.8M | −$645.4K | −$6.7M | −$756.9K | −$566.1K |
| Net margin | -5007.8% | -938.6% | -25329.4% | — | -7316.1% | -1123.8% | -107.7% | 599.4% |
| EPS (diluted) | -0.01 | -0.00 | -0.02 | -0.00 | -0.00 | -0.01 | -0.00 | 0.00 |
Annual figures · source: Financial Modeling Prep
Peer comparison
HEALIXA INC
HEALIXA INC
Held by traders on TradeandTell
No one on the platform currently holds EMOR.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in EMOR as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded EMOR yet.
